✦ LIBER ✦

The clinical impact of interferon beta antibodies in relapsing-remitting MS

✍ Scribed by Paola Perini; Massimiliano Calabrese; Giovanni Biasi; Paolo Gallo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of neutralizing antib

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

Outcome of beta-interferon treatment in

✍ K. O'Rourke; C. Walsh; M. Hutchinson 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 296 KB

Comparison of interferon beta products a

✍ M. Etemadifar; M. Janghorbani; V. Shaygannejad 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 264 KB

Impact of neutralizing antibodies on the

✍ Timothy Vartanian; Per Sölberg Sørensen; George Rice 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 313 KB

Study of binding and neutralising antibo

✍ Oscar Fernández; Cristobalina Mayorga; Gloria Luque; Miguel Guerrero; Rocío Guer 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 259 KB

Predictors of long–term clinical respons

✍ V. Tomassini; A. Paolillo; P. Russo; E. Giugni; L. Prosperini; C. Gasperini; G. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 261 KB